Axsome Therapeutics, Inc. (AXSM)
217.82
-4.81
(-2.16%)
USD |
NASDAQ |
May 07, 13:01
Axsome Therapeutics Free Cash Flow : -70.99M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Merck & Co., Inc. | 14.12B |
| Madrigal Pharmaceuticals, Inc. | -275.41M |
| Insmed, Inc. | -997.58M |
| AnaptysBio, Inc. | 19.61M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -20.70M |
| Cash from Investing (Quarterly) | -0.121M |
| Cash from Financing (Quarterly) | 2.994M |
| Free Cash Flow Per Share (Quarterly) | -0.4067 |
| Free Cash Flow to Equity (Quarterly) | -22.61M |
| Free Cash Flow to Firm (Quarterly) | -17.73M |
| Free Cash Flow Yield | -0.65% |